Abstracts tagged "gout and imaging techniques"

Abstract Number: 2586 • 2012 ACR/ARHP Annual Meeting
Tendon and Ligament Involvement in Gout: A Dual Energy Computed Tomography Study
Nicola Dalbeth¹, Ramanamma Kalluru², Opetaia Aati³, Fiona M. McQueen⁴ and Anthony Doyle⁵, ¹Medicine, University of Auckland, Auckland, New Zealand, ²Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, ³Department of Medicine, University of Auckland, Auckland, New Zealand, ⁴Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, ⁵University of Auckland, Auckland, New Zealand
Background/Purpose: The involvement of bone and joints is widely recognized in gout. However, soft tissue involvement is less well defined. Dual energy computed tomography (DECT)…
Abstract Number: 1035 • 2012 ACR/ARHP Annual Meeting
Characterisation of New Bone Formation in Gout: A Quantitative Site-by-Site Analysis Using Plain Radiography and Computed Tomography
Nicola Dalbeth¹, Aaron Milligan², Barnaby Clark², Fiona M. McQueen³ and Anthony Doyle⁴, ¹Medicine, University of Auckland, Auckland, New Zealand, ²Department of Radiology, Auckland District Health Board, Auckland, New Zealand, ³Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, ⁴University of Auckland, Auckland, New Zealand
Background/Purpose: Radiographic descriptions of gout have noted the tendency to hypertrophic bone changes. The aim of this study was to characterise the features of…
Abstract Number: 154 • 2012 ACR/ARHP Annual Meeting
Dual-Energy Computed Tomography As a Diagnostic Tool for Gout During Intercritical Periods
Gabriel S. Breuer¹, Naama Bogot² and Gideon Nesher³, ¹Rheumatology, Shaare Zedek Medical Center, Jerusalem, Israel, ²Radiology, Shaare Zedek Medical Center p o box 3235 Jerusalem, Israel, Israel, ³Internal Medicine, Shaare Zedek Medical Center, Jerusalem, Israel
Background/Purpose: Dual-energy computed tomography (DECT) is a sensitive method for identifying uric acid deposits in joints and periarticular soft tissues in patients suspected of having…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].